NDA 202395 describes ZIPRASIDONE HYDROCHLORIDE, which is a drug marketed by
Apotex,
Aurobindo Pharma,
Chartwell Rx,
Dr Reddys Labs Inc,
Lupin Pharms,
Macleods Pharms Ltd,
Mylan,
Sandoz Inc, and
Zydus Lifesciences, and is included in nine NDAs. It is available from
twenty suppliers. Additional details are available on the
ZIPRASIDONE HYDROCHLORIDE profile page.
The generic ingredient in ZIPRASIDONE HYDROCHLORIDE is
ziprasidone hydrochloride. There are twenty-three
drug master file entries for this compound. Twenty-two
suppliers are listed for this compound. Additional details are available on the
ziprasidone hydrochloride profile page.